Type 1 Diabetes Studies

Study Name	Principal Investigator
Immune Function During Various Stages of Insulin Dependent Diabetes	Mark Atkinson, Ph.D.
Non-Invasive Assessment of Pancreatic Volume as a Tool to Augment Risk Stratification in Patients at Risk for Type 1 Diabetes	Michael Haller, M.D.
Long Term Investigative Follow-Up in TrialNet (LIFT) Study	Desmond Schatz, M.D.
T1D Exchange Clinical Registry	Desmond Schatz, M.D. Janet Silverstein, M.D.
Fuzzy Logic Automated Insulin Regulation (FLAIR)	Desmond Schatz, M.D.
Afrezza Safety and Pharmacokinetics Study in Pediatric Patients
Lactobacillus Johnsonii Supplementation in Children and Adults With T1D	Michael Haller, M.D.
DiabeteS AUtoimmuNity WithdRawn In New OnSEt and In Established Patients (SUNRISE) A Phase 2 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety of TOL-3021 in Patients with New Onset or Established Type 1 Diabetes Mellitus	Laura Jacobsen, M.D.
Self-Efficacy for Managing Children with Type 1 Diabetes During the COVID-19 Pandemic	Anastasia Albanese-O’Neill, Ph.D., APRN, C.D.E